Cory Berkland
Cited by
Cited by
Effects of nanomaterial physicochemical properties on in vivo toxicity
KL Aillon, Y Xie, N El-Gendy, CJ Berkland, ML Forrest
Advanced drug delivery reviews 61 (6), 457-466, 2009
Nanotechnology in vaccine delivery
LJ Peek, CR Middaugh, C Berkland
Advanced drug delivery reviews 60 (8), 915-928, 2008
Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment
A Fakhari, C Berkland
Acta biomaterialia 9 (7), 7081-7092, 2013
Precise control of PLG microsphere size provides enhanced control of drug release rate
C Berkland, M King, A Cox, KK Kim, DW Pack
Journal of controlled release 82 (1), 137-147, 2002
Nanoparticles for biomedical imaging
SK Nune, P Gunda, PK Thallapally, YY Lin, M Laird Forrest, CJ Berkland
Expert opinion on drug delivery 6 (11), 1175-1194, 2009
Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions
C Berkland, KK Kim, DW Pack
Journal of controlled release 73 (1), 59-74, 2001
Nanoparticle formulations in pulmonary drug delivery
MM Bailey, CJ Berkland
Medicinal research reviews 29 (1), 196-212, 2009
K Kim, DW Pack, C Berkland
US Patent 6,669,961, 2003
PLG microsphere size controls drug release rate through several competing factors
C Berkland, K Kim, DW Pack
Pharmaceutical research 20, 1055-1062, 2003
Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres
C Berkland, MJ Kipper, B Narasimhan, KK Kim, DW Pack
Journal of Controlled Release 94 (1), 129-141, 2004
Practical considerations, challenges, and limitations of bioconjugation via azide–alkyne cycloaddition
CJ Pickens, SN Johnson, MM Pressnall, MA Leon, CJ Berkland
Bioconjugate chemistry 29 (3), 686-701, 2017
Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering
M Singh, C Berkland, MS Detamore
Tissue Engineering Part B: Reviews 14 (4), 341-366, 2008
Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution
C Raman, C Berkland, KK Kim, DW Pack
Journal of Controlled Release 103 (1), 149-158, 2005
PLGA nanoparticle− peptide conjugate effectively targets intercellular cell-adhesion molecule-1
N Zhang, C Chittasupho, C Duangrat, TJ Siahaan, C Berkland
Bioconjugate chemistry 19 (1), 145-152, 2008
ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells
C Chittasupho, SX Xie, A Baoum, T Yakovleva, TJ Siahaan, CJ Berkland
European journal of pharmaceutical sciences 37 (2), 141-150, 2009
Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects
Q Wang, J Wang, Q Lu, MS Detamore, C Berkland
Biomaterials 31 (18), 4980-4986, 2010
Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly (D, L-lactide-co-glycolide)
C Berkland, DW Pack, KK Kim
Biomaterials 25 (25), 5649-5658, 2004
Biodegradable colloidal gels as moldable tissue engineering scaffolds
Q Wang, L Wang, MS Detamore, C Berkland
Advanced Materials 20 (2), 236-239, 2008
Cell adhesion molecules for targeted drug delivery
AL Dunehoo, M Anderson, S Majumdar, N Kobayashi, C Berkland, ...
Journal of pharmaceutical sciences 95 (9), 1856-1872, 2006
NanoCipro encapsulation in monodisperse large porous PLGA microparticles
MM Arnold, EM Gorman, LJ Schieber, EJ Munson, C Berkland
Journal of Controlled Release 121 (1-2), 100-109, 2007
The system can't perform the operation now. Try again later.
Articles 1–20